Treatment of ATFL Tears With PRP

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Soft Tissue Healing

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06231134` - Diode Laser 940 nm Versus Electrosurgical Device During Second Stage Implant Surgery on Bone and Soft Tissue Healing	N/A
Completed	`NCT04353999` - The Effect of Laser Photocoagulation on the Soft Tissue Healing During Socket Preservation	N/A
Completed	`NCT05821673` - Soft Tissue Integration of Different Abutment Surfaces	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT06231134 - Diode Laser 940 nm Versus Electrosurgical Device During Second Stage Implant Surgery on Bone and Soft Tissue Healing

N/A

Completed

NCT04353999 - The Effect of Laser Photocoagulation on the Soft Tissue Healing During Socket Preservation

N/A

Completed

NCT05821673 - Soft Tissue Integration of Different Abutment Surfaces

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00725907
Study type	Interventional
Source	Meir Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 2008
Completion date	January 2009

Treatment of ATFL Tears With PRP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms